Covered recipient · General Payments record
EMILY SCHMALTZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2022–2024
$917.48
- Reported across 67 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $428.66 | 31 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $227.19 | 18 |
| Novo Nordisk AS | $43.89 | 3 |
| Insulet Corporation | $35.16 | 2 |
| Lilly USA, LLC | $32.51 | 2 |
| GlaxoSmithKline, LLC. | $31.44 | 2 |
| Abbott Laboratories | $29.58 | 2 |
| Acerta Pharma LLC | $14.76 | 1 |
| Astellas Pharma US Inc | $14.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.18 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125213469 | CMS |
| Abbott Laboratories | $13.40 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125213471 | CMS |
| ABBVIE INC. | $7.33 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155734 | CMS |
| ABBVIE INC. | $8.37 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155736 | CMS |
| ABBVIE INC. | $13.71 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155738 | CMS |
| ABBVIE INC. | $10.36 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155740 | CMS |
| ABBVIE INC. | $10.96 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155742 | CMS |
| ABBVIE INC. | $14.52 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155744 | CMS |
| ABBVIE INC. | $13.24 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155746 | CMS |
| ABBVIE INC. | $4.99 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155748 | CMS |
| ABBVIE INC. | $12.31 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155750 | CMS |
| ABBVIE INC. | $15.31 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155752 | CMS |
| ABBVIE INC. | $27.31 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155754 | CMS |
| ABBVIE INC. | $14.04 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155756 | CMS |
| ABBVIE INC. | $13.54 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155758 | CMS |
| ABBVIE INC. | $7.97 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155760 | CMS |
| ABBVIE INC. | $14.79 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155762 | CMS |
| ABBVIE INC. | $18.94 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155764 | CMS |
| ABBVIE INC. | $12.15 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155766 | CMS |
| ABBVIE INC. | $7.35 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108155768 | CMS |
| Astellas Pharma US Inc | $14.13 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139509485 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.76 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105366224 | CMS |
| GlaxoSmithKline, LLC. | $13.62 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116734742 | CMS |
| GlaxoSmithKline, LLC. | $17.82 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116254557 | CMS |
| Insulet Corporation | $14.04 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804460 | CMS |
| Insulet Corporation | $21.12 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811551 | CMS |
| Lilly USA, LLC | $19.37 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135661985 | CMS |
| Lilly USA, LLC | $13.14 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135622735 | CMS |
| Novo Nordisk Inc | $16.39 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100261067 | CMS |
| Novo Nordisk Inc | $13.84 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100325900 | CMS |
| Novo Nordisk Inc | $13.66 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100626876 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.